WO2002013780A1 - Creme de beaute - Google Patents

Creme de beaute Download PDF

Info

Publication number
WO2002013780A1
WO2002013780A1 PCT/PL2001/000072 PL0100072W WO0213780A1 WO 2002013780 A1 WO2002013780 A1 WO 2002013780A1 PL 0100072 W PL0100072 W PL 0100072W WO 0213780 A1 WO0213780 A1 WO 0213780A1
Authority
WO
WIPO (PCT)
Prior art keywords
vitamin
cream
cosmetic
cosmetic cream
skin
Prior art date
Application number
PCT/PL2001/000072
Other languages
English (en)
Inventor
Irena Szolomicka-Orfinger
Original Assignee
Szolomicka Orfinger Irena
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Szolomicka Orfinger Irena filed Critical Szolomicka Orfinger Irena
Priority to AU2001280310A priority Critical patent/AU2001280310A1/en
Publication of WO2002013780A1 publication Critical patent/WO2002013780A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins

Definitions

  • the subject of invention is a cosmetic cream.
  • the cream can be applied as a skin care agent that shields and regenerates the skin.
  • the popular and long-known cosmetic creams use a variety of additives in the form of herbal extracts, vitamins or other substances that serve the manufacturer's intended functions.
  • the American patent no US 5,510,391 describes the medical and cosmetic use of the vitamin K. As revealed in that patent, the method of absorption of skin extravasations, ruptures of blood vessels, utilises the vitamin K, previously used only in medical therapy, as a haemostatic agent. That patent indicates the possibility of using the vitamin K for the preparation of a pharmaceutical composition in the amount of even 50% of the composition volume, however without specifying effects of the application of vitamin K in relation to its concentration.
  • the European patent description no EP 0727985 points to the use of the vitamin K as an agent for the elimination of bloody extravasations, with the described composition having been made primarily on the alcohol' basis and also without describing effects of the application of a defined amount of the vitamin K.
  • a shortcoming of the offered preparations is the necessity to prepare a particular agent in accordance with an individual order, giving consideration to the condition and sensitivity level of the patient's skin. Hence, the necessity to apply such a preparation precisely in accordance with the recommendation and under control of a specialist - most frequently a physician - and also the exclusion of a possible application of such a preparation by persons that have sensitive skin, particularly to the effect of alcohol.
  • the purpose of this invention is to elaborate a new cosmetic cream, suitable for daily skin care and containing the vitamin K as the biologically active substance, destined to prevent and remove all types of extravasations, and also dilation of blood vessels, the so-called teleangiectasia.
  • vitamin K in an amount not exceeding several percent by weight as an additive to a cosmetic cream prepared on the basis of molecular compounds of fatty acids, a mixture of mineral and natural oils, glycerine and its compounds, fatty alcohols, silicones and preservatives.
  • the new cosmetic cream contains the vitamin K Phytonadione) in the amount from 0.01 to 5% by weight, preferably 1%, with the remaining 95 ⁇ 99.99% of the cream constituted jointly by: cosmetic base, UN filter, natural oil, preservatives and hypoallergic aromatic composition.
  • the cosmetic cream was subject to testing with respect to evaluation of the possible use of a cosmetic cream with 1% vitamin K for skin care purposes in the healing of lividity and reddening of the skin following injuries and surgical procedures.
  • the testing was conducted at the 1 st Faculty and Clinic of Surgery, 2 nd Department of Medicine, Medical University of Warsaw.
  • the test group was composed of 42 patients, among whom in 32 cases the injuries had not caused breaks in continuity of the skin, and in 10 cases hypodermic effusions had been associated with surgical treatment.
  • a cosmetic cream prepared on the basis of: mineral oil - 6.7%; isopropyl myristinate - 4.05%; glycerine - 3%; stearic acid diester - 3.0%; silicone oil - 2.0%; glycerol stearate - 2.0%; vitamin K - 1%;
  • the positive quality of the cream is the high efficiency of the vitamin K applied to the skin, confirmed by clinical tests, with the simultaneous lack of negative side effects, and also the possibility of using this preparation without the physician's control.
  • the cream also displays typical cosmetic and skin care qualities, such as: moisturising, enhancing skin elasticity, decreasing reddening, protecting against harmful UN radiation and nice, delicate fragrance of hypoallergic qualities.

Abstract

Crème de beauté destinée à prévenir l'apparition ou assurer la disparition de tous types d'extravasations et de vaisseaux sanguins dilatés, préparée sur la base cosmétique sous la forme de composés moléculaires d'acides gras, d'un mélange d'huiles minérales et naturelles, de la glycérine et de ses composés, d'alcools gras, de silicones, de filtres U.V., de conservants et d'une composition aromatique hypoallergique contenant de la vitamine K dans des quantités entre 0,01 et 5 % en poids.
PCT/PL2001/000072 2000-08-18 2001-08-17 Creme de beaute WO2002013780A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001280310A AU2001280310A1 (en) 2000-08-18 2001-08-17 Cosmetic cream

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PLP.342071 2000-08-18
PL34207100A PL342071A1 (en) 2000-08-18 2000-08-18 Cosmetic cream

Publications (1)

Publication Number Publication Date
WO2002013780A1 true WO2002013780A1 (fr) 2002-02-21

Family

ID=20077232

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/PL2001/000072 WO2002013780A1 (fr) 2000-08-18 2001-08-17 Creme de beaute

Country Status (3)

Country Link
AU (1) AU2001280310A1 (fr)
PL (1) PL342071A1 (fr)
WO (1) WO2002013780A1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003086375A1 (fr) * 2002-03-28 2003-10-23 Vitak Bv Systemes d'administration d'agents biologiquement actifs
FR2885802A1 (fr) * 2005-05-17 2006-11-24 Oreal Utilisation cosmetique de la vitamine k pour ameliorer la fonction barriere de la peau
US7745494B2 (en) 2005-04-15 2010-06-29 Albert Einstein College Of Medicine Of Yeshiva University Vitamin K for prevention and treatment of skin rash secondary to anti-EGFR therapy
US8815953B2 (en) 2008-03-13 2014-08-26 Spectrum Pharmaceuticals, Inc. Formulations of vitamin K analogs for topical use
US9428582B2 (en) 2006-07-03 2016-08-30 Genmab A/S Method of treating rash in patients undergoing anti-EGFR therapy
US9458236B2 (en) 2001-06-13 2016-10-04 Genmab A/S Human monoclonal antibodies to epidermal growth factor receptor (EGFR)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0521647A2 (fr) * 1991-06-25 1993-01-07 Unilever Plc Composition cosmétique
US5643587A (en) * 1996-02-15 1997-07-01 Avon Products, Inc. Composition and method for under-eye skin lightening

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0521647A2 (fr) * 1991-06-25 1993-01-07 Unilever Plc Composition cosmétique
US5643587A (en) * 1996-02-15 1997-07-01 Avon Products, Inc. Composition and method for under-eye skin lightening

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9458236B2 (en) 2001-06-13 2016-10-04 Genmab A/S Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
WO2003086375A1 (fr) * 2002-03-28 2003-10-23 Vitak Bv Systemes d'administration d'agents biologiquement actifs
US7745494B2 (en) 2005-04-15 2010-06-29 Albert Einstein College Of Medicine Of Yeshiva University Vitamin K for prevention and treatment of skin rash secondary to anti-EGFR therapy
EP2305224A2 (fr) 2005-04-15 2011-04-06 The Albert Einstein College Of Medicine Of Yeshiva University Analogue de la vitamine K pour le traitement des
EP2494965A2 (fr) 2005-04-15 2012-09-05 The Albert Einstein College Of Medicine Of Yeshiva University Vitamine K pour la prévention et le traitement des éruptions cutanées suite à une thérapie anti-egfr
US8283382B2 (en) 2005-04-15 2012-10-09 Albert Einstein College Of Medicine Of Yeshiva University Vitamin K for prevention and treatment of skin rash secondary to anti-EGFR therapy
FR2885802A1 (fr) * 2005-05-17 2006-11-24 Oreal Utilisation cosmetique de la vitamine k pour ameliorer la fonction barriere de la peau
US9428582B2 (en) 2006-07-03 2016-08-30 Genmab A/S Method of treating rash in patients undergoing anti-EGFR therapy
US8815953B2 (en) 2008-03-13 2014-08-26 Spectrum Pharmaceuticals, Inc. Formulations of vitamin K analogs for topical use

Also Published As

Publication number Publication date
PL342071A1 (en) 2001-02-12
AU2001280310A1 (en) 2002-02-25

Similar Documents

Publication Publication Date Title
Clark et al. Dermal implants: safety of products injected for soft tissue augmentation
HU230156B1 (hu) Hagymakivonatot és zsírolajat tartalmazó szer előállítása károsodott bőrszövet, különösen sebhelyek ellátására, megelőzésére vagy kezelésére
Yapar et al. Design and in vivo evaluation of emulgel formulations including green tea extract and rose oil
CN109481321A (zh) 一种美白祛斑的传明酸柔性脂质体及其制备方法和应用
CN106667804A (zh) 一种含有鸸鹋油的护肤组合物及其制备方法
WO2002013780A1 (fr) Creme de beaute
WO2019150292A1 (fr) Utilisation cosmétique d'eau de végétation
RU2530629C2 (ru) Вызываемая медикаментозными средствами липоатрофия для косметических целей
KR100941854B1 (ko) 오메가-3 지방산을 함유하는 피부 외용제 조성물
CN110025508B (zh) 一种预防妊娠纹产生的精华霜及其制备方法
CN108354891B (zh) 一种舒缓乳霜及其制备方法
KR102324984B1 (ko) 피부 혈류 개선 효과를 위한 피부 도포용 천연 에센셜 오일 조성물 및 이를 포함하는 화장료 조성물
CN107823637B (zh) 一种蛭肽蛋白乳膏剂及其制备方法和应用
JP2021506985A (ja) 瘢痕を最小化することにおける使用のための神経毒
EP1453526A2 (fr) Composition pharmaceutique pour le traitement topique d'affections cutanees et de lesions cutanees
JP2008169196A (ja) 皮膚外用剤
Kovács et al. Lack of the effect of topical vitamin K on bruising after mechanical injury
JP6920031B2 (ja) 慢性角化型湿疹改善剤
Sutton Pulmonary fat embolism
KR102641072B1 (ko) 립밤 조성물 및 이를 포함하여 제조된 립밤
WO2023234345A1 (fr) Préparation cutanée externe contenant un concentré non saponifié d'huile de son de riz
JP2019073448A (ja) メラノサイトを保護するための外用剤
US20230038636A1 (en) Kit including biotin for harvesting platelet-rich plasma
KR101212899B1 (ko) 오메가-3 지방산을 함유하는 피부 외용제 조성물
BAREFOOT et al. Temporal (giant-cell) arteritis associated with ulcerations of scalp

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP